Author

Michel Kayomo Kaswa

Observed names: Kaswa, Michel K., Kaswa, Michel Kayomo, M. Kaswa, Michel K. Kaswa, Michel K Kaswa, Michel K. Kaswa, Michel Kaswa, Michel Kaswa Kayomo

Observed institutions: South African Medical Research Council, Ministry of Public Health, New York State Department of Health, Wadsworth Center, University of Antwerp, United States Agency for International Development, University of Kinshasa, National Institute of Biomedical Research, Instituut voor Tropische Geneeskunde

ORCID: 0000-0003-3260-7248

Observed ORCID: 0000-0003-3260-7248

OpenAlex ID: A5084680163

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

2020 · Jean Claude Semuto Ngabonziza, Chloé Loiseau, et al. · Nature Communications · 229

PDF

The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology

2018 · Conor J. Meehan, Pieter Moris, et al. · EBioMedicine · 141

PDF

Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs

2020 · Agathe Jouet, Cyril Gaudin, et al. · European Respiratory Journal · 125

PDF

Sequencing of the pncA Gene in Members of the Mycobacterium tuberculosis Complex Has Important Diagnostic Applications: Identification of a Species-Specific pncA Mutation in “ Mycobacterium canettii ” and the Reliable and Rapid Predictor of Pyrazinamide Resistance

2006 · Akos Somoskovi, Jillian Dormandy, et al. · Journal of Clinical Microbiology · 65

An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo

2009 · J.J. Muyembe-Tamfum, J. Veyi, et al. · Travel Medicine and Infectious Disease · 58

Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo

2014 · P. Mitashi, E. Hasker, et al. · Tropical Medicine & International Health · 34

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo

2018 · Michel Kaswa Kayomo, Epco Hasker, et al. · Emerging infectious diseases · 30

PDF

Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF–identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012–2017: A Retrospective Province-Wide Cohort Study

2018 · André N H Bulabula, Jenna A Nelson, et al. · Clinical Infectious Diseases · 27

PDF

Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo

2020 · Michel Kaswa Kayomo, Vital Nkake Mbula, et al. · Scientific Reports · 25

PDF

Pseudo-Outbreak of Pre-Extensively Drug-Resistant (Pre-XDR) Tuberculosis in Kinshasa: Collateral Damage Caused by False Detection of Fluoroquinolone Resistance by GenoType MTBDR sl

2014 · Michel K. Kaswa, Muriel Aloni, et al. · Journal of Clinical Microbiology · 23

The economic burden of TB-affected households in DR Congo

2021 · M. Kaswa, G. Minga, et al. · The International Journal of Tuberculosis and Lung Disease · 22

Xpert My cobacterium tuberculosis/Rifampicin–Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications

2020 · Bertin C Bisimwa, Jean B Nachega, et al. · Clinical Infectious Diseases · 20

Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study

2020 · Innocent Murhula Kashongwe, Fina Mawete, et al. · PLoS ONE · 17

PDF

Challenge to treat pre-extensively drug-resistant tuberculosis in a low-income country: A report of 12 cases

2020 · Innocent Murhula Kashongwe, Fina Mawete, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 10

PDF

Multi Drug Resistant Tuberculosis in Mosango, a Rural Area in the Democratic Republic of Congo

2014 · Michel Kayomo Kaswa, Serge Bisuta, et al. · PLoS ONE · 9

PDF

Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings

2022 · Armand Van Deun, Valentin Bola, et al. · JAC-Antimicrobial Resistance · 7

PDF

Factors Associated with Mortality among Multidrug Resistant Tuberculosis MDR/RR-TB Patients in Democratic Republic of Congo

2017 · Murhula Innocent Kashongwe, Leopoldine Mbulula, et al. · Journal of Tuberculosis Research · 7

PDF

Implementing a Short Regimen for Multidrug-Resistant Tuberculosis in Kinshasa, Democratic Republic of Congo: A Cohort Study 2014-2017

2020 · Innocent Murhula Kashongwe, Leopoldine Mbulula, et al. · Journal of Tuberculosis Research · 6

PDF

Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa

2025 · Faridath Massou, Bassirou Diarra, et al. · ERJ Open Research · 5

Séroprévalence du VIH chez les tuberculeux à Kisangani en République Démocratique du Congo

2013 · Jean Musafiri, Patrick Matala Mbayo, et al. · Santé Publique · 5

PDF

Extensively resistant tuberculosis: Four cases in the Republic of Congo

2018 · F.H. Okemba Okombi, E. Bemba, et al. · Médecine et Santé Tropicales · 4

Sensorineural Hearing Loss in Multidrug-Resistant Tuberculosis Patients in Kinshasa (Democratic Republic of Congo): Prospective Cohort Study of Therapeutic Regimen with Aminoglycoside versus Bedaquiline

2023 · Mireille A. Mpwate, Eddy M. Mbambu, et al. · Journal of Tuberculosis Research · 3

PDF

First Use of Bedaquiline in Democratic Republic of Congo: Two Case Series of Pre Extensively Drug Resistant Tuberculosis

2018 · Murhula Innocent Kashongwe, Leopoldine Mbulula, et al. · Journal of Tuberculosis Research · 3

PDF

Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017

2019 · Innocent Kashongwe Murhula, Fina Mawete, et al. · Journal of Tuberculosis Research · 2

PDF

Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting

2025 · Bertin C Bisimwa, Maja Kiselinova, et al. · Clinical Infectious Diseases · 1

Works count: 39

Citation count: 881

H-index: 13

I10-index: 14